These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39439002)

  • 1. A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson's disease.
    Wang Z; Gilliland T; Kim HJ; Gerasimenko M; Sajewski K; Camacho MV; Bebek G; Chen SG; Gunzler SA; Kong Q
    Acta Neuropathol Commun; 2024 Oct; 12(1):167. PubMed ID: 39439002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.
    Wang Z; Gilliland T; Kim HJ; Gerasimenko M; Sajewski K; Camacho MV; Bebek G; Chen SG; Gunzler SA; Kong Q
    medRxiv; 2024 Jun; ():. PubMed ID: 38978648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
    Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy.
    Luan M; Wei L; Sun Y; Chen J; Jiang Y; Wu W; Li F; Sun W; Zhu L; Wang Z; Deng J
    Parkinsonism Relat Disord; 2024 Oct; 127():107088. PubMed ID: 39111257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
    Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
    Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson's disease.
    Mao H; Kuang Y; Feng D; Chen X; Lu L; Xia W; Gan T; Huang W; Guo W; Yi H; Yang Y; Wu Z; Dai W; Sun H; Wu J; Zhang R; Zhang S; Lin X; Yong Y; Yang X; Li H; Wu W; Huang X; Bian Z; Wong HLX; Wang XL; Poppell M; Ren Y; Liu C; Zou WQ; Chen S; Xu PY
    Transl Neurodegener; 2024 Jul; 13(1):35. PubMed ID: 39049095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
    Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
    Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies.
    Coughlin DG; MacLeod KR; Middleton JS; Bozoki AC; Galvin JE; Irwin DJ; Lippa CF; Litvan I; Lopez OL; Berman S; Tsuang DW; Zabetian CP; Honig LS; Marder KS; Fleisher JE; Sabbagh M; Wint D; Taylor AS; Bekris L; Leverenz JB; Galasko D
    Neurology; 2024 Aug; 103(3):e209656. PubMed ID: 39013126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
    Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
    Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.
    Majbour N; Aasly J; Abdi I; Ghanem S; Erskine D; van de Berg W; El-Agnaf O
    Neurology; 2022 Nov; 99(21):e2417-e2427. PubMed ID: 36096686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.
    Fernandes Gomes B; Farris CM; Ma Y; Concha-Marambio L; Lebovitz R; Nellgård B; Dalla K; Constantinescu J; Constantinescu R; Gobom J; Andreasson U; Zetterberg H; Blennow K
    Parkinsonism Relat Disord; 2023 Dec; 117():105807. PubMed ID: 37591709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease.
    Angius F; Mocci I; Ercoli T; Loy F; Fadda L; Palmas MF; Cannas G; Manzin A; Defazio G; Carta AR
    J Neurol; 2023 Nov; 270(11):5613-5621. PubMed ID: 37552278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson's Disease Diagnosis and Duration.
    Schaeffer E; Kluge A; Schulte C; Deuschle C; Bunk J; Welzel J; Maetzler W; Berg D
    J Parkinsons Dis; 2024; 14(4):667-679. PubMed ID: 38669557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
    Bentivenga GM; Mammana A; Baiardi S; Rossi M; Ticca A; Magliocchetti F; Mastrangelo A; Poleggi A; Ladogana A; Capellari S; Parchi P
    Acta Neuropathol; 2024 Jan; 147(1):18. PubMed ID: 38240849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seed amplification assay results illustrate discrepancy in Parkinson's disease clinical diagnostic accuracy and error rates.
    Middleton JS; Hovren HL; Kha N; Medina MJ; MacLeod KR; Concha-Marambio L; Jensen KJ
    J Neurol; 2023 Dec; 270(12):5813-5818. PubMed ID: 37592136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC.
    Groveman BR; Orrù CD; Hughson AG; Raymond LD; Zanusso G; Ghetti B; Campbell KJ; Safar J; Galasko D; Caughey B
    Acta Neuropathol Commun; 2018 Feb; 6(1):7. PubMed ID: 29422107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin α-Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease.
    LoPiccolo MK; Wang Z; Eshed GM; Fierro L; Stauffer C; Wang K; Zhang J; Tatsuoka C; Balwani M; Zou WQ; Alcalay RN
    Mov Disord; 2024 Nov; 39(11):2087-2091. PubMed ID: 39021250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.
    Manne S; Kondru N; Jin H; Serrano GE; Anantharam V; Kanthasamy A; Adler CH; Beach TG; Kanthasamy AG
    Mov Disord; 2020 Dec; 35(12):2230-2239. PubMed ID: 32960470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays.
    Srivastava A; Wang Q; Orrù CD; Fernandez M; Compta Y; Ghetti B; Zanusso G; Zou WQ; Caughey B; Beauchemin CAA
    PLoS Pathog; 2024 Sep; 20(9):e1012554. PubMed ID: 39302978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.